Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium

Combination therapy with ampicillin, vancomycin, and gentamicin in vitro against several clinical isolates of vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium, including VanA and VanB strains, was evaluated. The MICs of ampicillin were not significantly decreased by induction with vancomycin, and the combination of ampicillin and vancomycin was not inhibitory for any strain. Triple-combination therapy was least active against highly resistant VanA isolates, achieving a reduction of less than 1 log CFU at 24 h, but demonstrated slightly more activity against VanB strains.

[1]  B. Cookson,et al.  Vancomycin-resistant enterococci , 1993, The Lancet.

[2]  A. Rodloff,et al.  Overproduction of a penicillin-binding protein is not the only mechanism of penicillin resistance in Enterococcus faecium , 1992, Antimicrobial Agents and Chemotherapy.

[3]  S. Handwerger,et al.  Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. Heijenoort,et al.  Inducible carboxypeptidase activity in vancomycin-resistant enterococci , 1992, Antimicrobial Agents and Chemotherapy.

[5]  L. Gutmann,et al.  Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin , 1991, Antimicrobial Agents and Chemotherapy.

[6]  C. Walsh,et al.  Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity. , 1991, Biochemistry.

[7]  J. Duval,et al.  Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci , 1991, Antimicrobial Agents and Chemotherapy.

[8]  Claude Carbón,et al.  Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium. , 1991, The Journal of infectious diseases.

[9]  N. Woodford,et al.  Resistance to vancomycin and teicoplanin: an emerging clinical problem , 1990, Clinical Microbiology Reviews.

[10]  A. Kaplan,et al.  Recovery of resistant enterococci during vancomycin prophylaxis , 1988, Journal of clinical microbiology.

[11]  L. Gutmann,et al.  One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. , 1985, Journal of general microbiology.